Impact of an Interleukin-1 Receptor Antagonist and Erythropoietin on Experimental Myocardial Ischemia/Reperfusion Injury

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Grothusen, Christina ^a   Hagemann, Angelika ^a   Attmann, Tim ^a   Braesen, Jan ^a   Broch, Ole ^a   Cremer, Jochen ^a   Schoettler, Jan ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; AGRIN; CD86 ANTIGEN; ERYTHROPOIETIN; FAS LIGAND; FRACTALKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; L SELECTIN; LEPTIN; PROLACTIN RECEPTOR; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CYTOKINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; DRUG MECHANISM; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; RAT; REPERFUSION INJURY; ANIMAL; BLOOD; DRUG ANTAGONISM; HEART INFARCTION; LEWIS RAT; METABOLISM;

ANIMALS; CYTOKINES; ERYTHROPOIETIN; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, INBRED LEW; RECEPTORS, INTERLEUKIN-1; TROPONIN T;

EID: 84862312444     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/737585     Document Type: Article

References (24)

1. Bailey J. J., Berson A. S., Handelsman H., Hodges M., Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction Journal of the American College of Cardiology 2001 38 7 1902 1911 (Pubitemid 33116562)
2. McGovern P. G., Jacobs D. R. Jr., Shahar E., Arnett D. K., Folsom A. R., Blackburn H., Luepker R. V., Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the minnesota heart survey Circulation 2001 104 1 19 24 (Pubitemid 32623284)
3. Simoons M. L., Boersma E., Maas A. C., Deckers J. W., Management of myocardial infarction: the proper priorities European Heart Journal 1997 18 6 896 899 (Pubitemid 27230659)
4. Wijns W., Kolh P., Danchin N., Guidelines on myocardial revascularization: the task force on myocardial revascularization of the european society of cardiology (ESC) and the european association for cardio-thoracic surgery (EACTS) European Heart Journal 2010 31 20 2501 2555
5. Weiss E. S., Chang D. D., Joyce D. L., Nwakanma L. U., Yuh D. D., Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data Journal of Thoracic and Cardiovascular Surgery 2008 135 3 503 511
6. Morrison D. A., Sacks J., Balancing benefit against risk in the choice of therapy for coronary artery disease: lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery Minerva Cardioangiologica 2003 51 5 585 597 (Pubitemid 38029785)
7. Yellon D. M., Hausenloy D. J., Myocardial reperfusion injury The New England Journal of Medicine 2007 357 11 1121 1135
8. Merhi-Soussi F., Kwak B. R., Magne D., Chadjichristos C., Berti M., Pelli G., James R. W., MacH F., Gabay C., Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice Cardiovascular Research 2005 66 3 583 593 (Pubitemid 40725770)
9. Chamberlain J., Francis S., Brookes Z., Shaw G., Graham D., Alp N. J., Dower S., Crossman D. C., Interleukin-1 regulates multiple atherogenic mechanisms in response to fat feeding PLoS One 2009 4 4
10. Parti G., D'Ambrosio A., Mega S., Giorgi G., Zardi E. M., Zardi D. M., Dicuonzo G., Dobrina A., Di Sciascio G., Early Interleukin-1 receptor antagonist elevation in patients with acute myocardial infarction Journal of the American College of Cardiology 2004 43 1 35 38 (Pubitemid 38045911)
11. Patti G., Mega S., Pasceri V., Nusca A., Giorgi G., Zardi E. M., D'Ambrosio A., Dobrina A., Di Sciascio G., Interleukin-1 receptor antagonist levels correlate with extent of myocardial loss in patients with acute myocardial infarction Clinical Cardiology 2005 28 4 193 196 (Pubitemid 40471702)
12. Salloum F. N., Chau V., Varma A., Hoke N. N., Toldo S., Biondi-Zoccai G. G. L., Crea F., Vetrovec G. W., Abbate A., Anakinra in experimental acute myocardial infarction-does dosage or duration of treatment matter? Cardiovascular Drugs and Therapy 2009 23 2 129 135
13. Fearon W. F., Fearon D. T., Inflammation and cardiovascular disease role of the interleukin-1 receptor antagonist Circulation 2008 117 20 2577 2579
14. Vogiatzi G., Briasoulis A., Tousoulis D., Papageorgiou N., Stefanadis C., Is there a role for erythropoietin in cardiovascular disease? Expert Opinion on Biological Therapy 2010 10 2 251 264
15. O'Brien P. J., Dameron G. W., Beck M. L., Kang Y. J., Kipp Erickson B., Di Battista T. H., Miller K. E., Jackson K. N., Mittelstadt S., Cardiac troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animals Laboratory Animal Science 1997 47 5 486 495
16. Garcia-Rivas G. J., Torre-Amione G., Abnormal mitochondrial function during ischemia reperfusion provides targets for pharmacological therapy Methodist Debakey Cardiovascular Journal 2009 5 3 2 7
17. Abbate A., Salloum F. N., Vecile E., Das A., Hoke N. N., Straino S., Giuseppe G. L., Biondi-Zoccai, Houser J. E., Qureshi I. Z., Ownby E. D., Gustini E., Biasucci L. M., Severino A., Capogrossi M. C., Vetrovec G. W., Crea F., Baldi A., Kukreja R. C., Dobrina A., Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction Circulation 2008 117 20 2670 2683
18. Ikonomidis I., Lekakis J. P., Nikolaou M., Paraskevaidis I., Andreadou I., Kaplanoglou T., Katsimbri P., Skarantavos G., Soucacos P. N., Kremastinos D. T., Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis Circulation 2008 117 20 2662 2669
19. Sharma M., Ganguly N. K., Chaturvedi G., Thingnam S. K., Majumdar S., Suri R. K., Release of pro-inflammatory mediators during myocardial ischemia/reperfusion in coronary artery bypass graft surgery Molecular and Cellular Biochemistry 2003 247 1-2 23 30 (Pubitemid 36798505)
20. Mastromarino V., Volpe M., Musumeci M. B., Autore C., Conti E., Erythropoietin and the heart: facts and perspectives Clinical Science 2011 120 2 51 63
21. Vogiatzi G., Briasoulis A., Tousoulis D., Papageorgiou N., Stefanadis C., Is there a role for erythropoietin in cardiovascular disease? Expert Opinion on Biological Therapy 2010 10 2 251 264
22. Klopsch C., Furlani D., Gabel R., Li W., Pittermann E., Ugurlucan M., Kundt G., Zingler C., Titze U., Wang W., Ong L. L., Wagner K., Li R. K., Ma N., Steinhoff G., Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model Journal of Cellular and Molecular Medicine 2009 13 4 664 679
23. Baker J. E., Kozik D., Hsu A. K., Fu X., Tweddell J. S., Gross G. J., Darbepoetin alfa protects the rat heart against infarction: dose-response, phase of action, and mechanisms Journal of Cardiovascular Pharmacology 2007 49 6 337 345 (Pubitemid 47000307)
24. Ott I., Schulz S., Mehilli J., Fichtner S., Hadamitzky M., Hoppe K., Ibrahim T., Martinoff S., Massberg S., Laugwitz K.-L., Dirschinger J., Schwaiger M., Kastrati A., Schomig A., Erythropoietin in patients with acute st-segment elevation myocardial infarction undergoing primary: percutaneous coronary intervention a randomized, double-blind trial Circulation 2010 3 5 408 413